A - Human Necessities – 61 – M
Patent
A - Human Necessities
61
M
A61M 1/38 (2006.01) A61L 2/00 (2006.01) A61M 1/34 (2006.01) A61M 1/36 (2006.01) B01D 63/04 (2006.01) B03C 5/02 (2006.01)
Patent
CA 2264345
A method and apparatus for preventing and treating septicemia in patient blood. The extracorporeal system includes an anti-microbial device to kill at least 99% of bloodborne microorganisms, a hemoconcentrator/filtration unit to remove approximately 90% of target molecules from the patient blood and a filter unit to remove target molecules from patient blood from the sieved plasma filtrate. Target molecules are produced by microorganisms as well as the patient's cells and include endotoxins from gram negative bacteria, exotoxins from gram negative and gram positive bacteria, as well as RAP protein mediator from Staphylococcus aureus, and cell mediators such as tumor necrosis factor-alpha, and interleukin 1-beta, complement proteins C3a and C5a, and brandykinin.
Chan Richard G. L.
Davidner Alan
Roohk H. Vernon
American Immuno Tech Llc.
Hemavation Llc
Kirby Eades Gale Baker
LandOfFree
Septicemia prevention and treatment system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Septicemia prevention and treatment system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Septicemia prevention and treatment system will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2014149